World news and discussion on TalkFuse.
Bipartisan resistance prompts withdrawal of Overton’s FDA nomination before vote
Developing story first seen 1 hour ago
Newly reported details indicate Overton’s nomination faced bipartisan opposition, with concern among senators extending across party lines. The White House withdrew her bid to lead the Food and Drug Administration on the eve of her confirmation vote after she failed to secure enough support.
Overton is a physician and deputy director of the White House Domestic Policy Council. Critics cited her alleged ties to the tobacco industry, support for vaping and anti-abortion stance; signs opposing her nomination appeared on Capitol Hill in recent days.
- Sources
- 2
- Outlets
- 2
- Left · Centre · Right
- 1 · 0 · 1
In short
- Overton’s FDA nomination was withdrawn before a Senate vote.
- She lacked sufficient support among senators from both parties.
- Critics raised concerns over vaping, tobacco ties and abortion.
How this story developed
- 5 minutes ago The White House withdrew Overton’s nomination on the eve of the vote after she failed to gain sufficient support from senators across party lines.
- 10 minutes ago Heidi Overton’s bid to lead the FDA faced bipartisan opposition, with senators citing her alleged tobacco industry links, support for vaping and anti-abortion stance ahead of a confirmation vote.
Where outlets differ
Left-leaning outlets 1
Only here: white, house, withdraws, heidi, lead
Right-leaning outlets 1
Only here: bipartisan, resistance, prompts, withdrawal, vote
Every side used: nomination, overton
Headline columns compared word for word; nothing in them is AI-written.
Coverage · 2 sources
Bias meters
From 2 rated sources.
Read the full article at the source →
Originally published by New York Post as “White House withdraws Heidi Overton’s FDA nomination after Trump pick received bipartisan pushback”.